2026
A multicenter dose-defining/expansion phase 1b study of first-line regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma.
Hepatology (Baltimore, Md.)
PubMed • Publisher's siteTransplant Hepatologist
83 publications
2026
Hepatology (Baltimore, Md.)
PubMed • Publisher's site2026
JAMA internal medicine
PubMed • Publisher's site2026
The Journal of surgical research
PubMed • Publisher's site2025
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
PubMed • Publisher's site2025
American journal of veterinary research
PubMed • Publisher's site